miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation
出版年份 2015 全文链接
标题
miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation
作者
关键词
miR-150, Pertuzumab, Ovarian cancer, Drug resistance
出版物
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Volume 292, Issue 5, Pages 1109-1116
出版商
Springer Nature
发表日期
2015-05-18
DOI
10.1007/s00404-015-3742-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1
- (2014) M. Mraz et al. BLOOD
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNA-150 Predicts a Favorable Prognosis in Patients with Epithelial Ovarian Cancer, and Inhibits Cell Invasion and Metastasis by Suppressing Transcriptional Repressor ZEB1
- (2014) Minfei Jin et al. PLoS One
- Pertuzumab: Optimizing HER2 Blockade
- (2013) O. Metzger-Filho et al. CLINICAL CANCER RESEARCH
- The role of miR-150 in normal and malignant hematopoiesis
- (2013) Y He et al. ONCOGENE
- FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway
- (2012) Jingyi Zhou et al. Autophagy
- Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage
- (2012) Jing Han et al. Autophagy
- Trastuzumab and Pertuzumab Produce Changes in Morphology and Estrogen Receptor Signaling in Ovarian Cancer Xenografts Revealing New Treatment Strategies
- (2011) D. Faratian et al. CLINICAL CANCER RESEARCH
- HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
- (2011) Devika Gajria et al. Expert Review of Anticancer Therapy
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- FOXO1A Is a Target for HER2-Overexpressing Breast Tumors
- (2010) Y. Wu et al. CANCER RESEARCH
- Pertuzumab for the treatment of ovarian cancer
- (2010) Simon P Langdon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Enhancement of paclitaxel-induced apoptosis in HER2-overexpressing human breast cancer cells by a pertuzumab mimetic peptide, HRAP
- (2010) Hiroo Nakajima et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab
- (2009) E. Yao et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More